| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $3.0M | +216.4% |
| R&D Expense | $18.2M | +35.6% |
| SG&A Expense | $34.7M | -8.9% |
| Operating Income | -$56.4M | -8.6% |
| Interest Expense | $1.3M | — |
| Net Income | -$53.7M | -4.0% |
| EPS (Basic) | -$7.59 | -2271.9% |
| EPS (Diluted) | -$7.59 | -2271.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.3M | -42.7% |
| Inventory | $906K | -61.5% |
| Current Assets | $41.0M | -42.0% |
| Total Assets | $48.7M | -39.2% |
| Current Liabilities | $8.7M | -4.9% |
| Long-term Debt | $13.4M | — |
| Total Liabilities | $33.1M | +113.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.5M | -2.5% |
| Capital Expenditures | $28K | +75.0% |
| Investing Cash Flow | $18K | +212.5% |
| Financing Cash Flow | $23.5M | +203.9% |
| Free Cash Flow | -$51.5M | -2.6% |
| Stockholders' Equity |
| $15.6M |
| -75.9% |